Suppr超能文献

肝细胞肿瘤坏死因子受体相关因子 6 通过促进凋亡信号调节激酶 1 的赖氨酸 6 连接多泛素化加剧肝脏炎症和纤维化。

Hepatocyte TNF Receptor-Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6-Linked Polyubiquitination of Apoptosis Signal-Regulating Kinase 1.

机构信息

College of Life Sciences, Department of Cardiology, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.

Institute of Model Animal of Wuhan University, Wuhan, China.

出版信息

Hepatology. 2020 Jan;71(1):93-111. doi: 10.1002/hep.30822. Epub 2019 Aug 20.

Abstract

Activation of apoptosis signal-regulating kinase 1 (ASK1) is a key driving force of the progression of nonalcoholic steatohepatitis (NASH) and represents an attractive therapeutic target for NASH treatment. However, the molecular and cellular mechanisms underlying ASK1 activation in the pathogenesis of NASH remain incompletely understood. In this study, our data unequivocally indicated that hyperactivated ASK1 in hepatocytes is a potent inducer of hepatic stellate cell (HSC) activation by promoting the production of hepatocyte-derived factors. Our previous serial studies have shown that the ubiquitination system plays a key role in regulating ASK1 activity during NASH progression. Here, we further demonstrated that tumor necrosis factor receptor-associated factor 6 (TRAF6) promotes lysine 6 (Lys6)-linked polyubiquitination and subsequent activation of ASK1 to trigger the release of robust proinflammatory and profibrotic factors in hepatocytes, which, in turn, drive HSC activation and hepatic fibrosis. Consistent with the in vitro findings, diet-induced liver inflammation and fibrosis were substantially attenuated in Traf6 mice, whereas hepatic TRAF6 overexpression exacerbated these abnormalities. Mechanistically, Lys6-linked ubiquitination of ASK1 by TRAF6 facilitates the dissociation of thioredoxin from ASK1 and N-terminal dimerization of ASK1, resulting in the boosted activation of ASK1-c-Jun N-terminal kinase 1/2 (JNK1/2)-mitogen-activated protein kinase 14(p38) signaling cascade in hepatocytes. Conclusion: These results suggest that Lys6-linked polyubiquitination of ASK1 by TRAF6 represents a mechanism underlying ASK1 activation in hepatocytes and a key driving force of proinflammatory and profibrogenic responses in NASH. Thus, inhibiting Lys6-linked polyubiquitination of ASK1 may serve as a potential therapeutic target for NASH treatment.

摘要

激活凋亡信号调节激酶 1(ASK1)是促进非酒精性脂肪性肝炎(NASH)进展的关键驱动力,代表了 NASH 治疗的有吸引力的治疗靶点。然而,ASK1 在 NASH 发病机制中的激活的分子和细胞机制仍不完全清楚。在这项研究中,我们的数据明确表明,肝细胞中高活性的 ASK1 通过促进肝细胞源性因子的产生,是肝星状细胞(HSC)激活的有力诱导剂。我们之前的一系列研究表明,泛素化系统在调节 NASH 进展过程中 ASK1 的活性中起关键作用。在这里,我们进一步证明肿瘤坏死因子受体相关因子 6(TRAF6)促进赖氨酸 6(Lys6)连接的多泛素化,随后激活 ASK1,从而引发肝细胞中强烈的促炎和促纤维化因子的释放,进而驱动 HSC 激活和肝纤维化。与体外研究结果一致,Traf6 小鼠中饮食诱导的肝炎症和纤维化明显减轻,而肝 TRAF6 过表达加剧了这些异常。从机制上讲,TRAF6 对 ASK1 的 Lys6 连接泛素化促进了硫氧还蛋白从 ASK1 上的解离和 ASK1 的 N 端二聚化,从而增强了 ASK1-c-Jun N 末端激酶 1/2(JNK1/2)-丝裂原活化蛋白激酶 14(p38)信号通路在肝细胞中的激活。结论:这些结果表明,TRAF6 对 ASK1 的 Lys6 连接多泛素化代表了 ASK1 在肝细胞中激活的机制,也是 NASH 中促炎和促纤维化反应的关键驱动力。因此,抑制 ASK1 的 Lys6 连接多泛素化可能成为 NASH 治疗的潜在治疗靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验